BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31718480)

  • 1. In silico identification of microRNAs as candidate colorectal cancer biomarkers.
    Fadaka AO; Klein A; Pretorius A
    Tumour Biol; 2019 Nov; 41(11):1010428319883721. PubMed ID: 31718480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In silico identification of key genes and signaling pathways targeted by a panel of signature microRNAs in prostate cancer.
    Baruah MM; Sharma N
    Med Oncol; 2019 Apr; 36(5):43. PubMed ID: 30937635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification and Interaction Analysis of Molecular Markers in Colorectal Cancer by Integrated Bioinformatics Analysis.
    Han B; Feng D; Yu X; Zhang Y; Liu Y; Zhou L
    Med Sci Monit; 2018 Aug; 24():6059-6069. PubMed ID: 30168505
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In Silico Integration Approach Reveals Key MicroRNAs and Their Target Genes in Follicular Thyroid Carcinoma.
    Hu S; Liao Y; Zheng J; Gou L; Regmi A; Zafar MI; Chen L
    Biomed Res Int; 2019; 2019():2725192. PubMed ID: 31032340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of Target Genes and Pathways Associated With Cetuximab Insensitivity in Colorectal Cancer.
    Yu C; Hong H; Lu J; Zhao X; Hu W; Zhang S; Zong Y; Mao Z; Li J; Wang M; Feng B; Sun J; Zheng M
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818806905. PubMed ID: 30336768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Prediction of Candidate MicroRNAs for CRC Management Using in Silico Approach.
    Fadaka AO; Pretorius A; Klein A
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a 5‑microRNA signature and hub miRNA‑mRNA interactions associated with pancreatic cancer.
    Ma X; Tao R; Li L; Chen H; Liu Z; Bai J; Shuai X; Wu C; Tao K
    Oncol Rep; 2019 Jan; 41(1):292-300. PubMed ID: 30365134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA Assisted Gene Regulation in Colorectal Cancer.
    Fadaka AO; Pretorius A; Klein A
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analyses of molecular pathways and key candidate biomarkers associated with colorectal cancer.
    Pirim D
    Cancer Biomark; 2020; 27(4):555-568. PubMed ID: 32176635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic profiling of microRNA target genes in colorectal cancer.
    Fadaka AO; Bakare OO; Pretorius A; Klein A
    Tumour Biol; 2020 Jun; 42(6):1010428320933512. PubMed ID: 32552466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
    Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
    Gene; 2019 May; 698():9-18. PubMed ID: 30825595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Analysis of miRNA and their Gene Targets Significantly Involved in Colorectal Cancer Progression.
    Kandhavelu J; Subramanian K; Khan A; Omar A; Ruff P; Penny C
    Microrna; 2019; 8(1):68-75. PubMed ID: 30073936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
    Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
    World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Yang Q; Qi M; Chen Y; Tian S; Liao F; Dong W
    DNA Cell Biol; 2021 Jul; 40(7):921-935. PubMed ID: 34042518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
    Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
    Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of biomarkers associated with diagnosis and prognosis of colorectal cancer patients based on integrated bioinformatics analysis.
    Chen L; Lu D; Sun K; Xu Y; Hu P; Li X; Xu F
    Gene; 2019 Apr; 692():119-125. PubMed ID: 30654001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer.
    Liang Y; Zhang C; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Dec; 24(46):5259-5270. PubMed ID: 30581274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of the Anti-Tumor Mechanism of Calycosin Against Colorectal Cancer by Using System Pharmacology Approach.
    Huang C; Li R; Shi W; Huang Z
    Med Sci Monit; 2019 Jul; 25():5589-5593. PubMed ID: 31352466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative systematic review meta-analysis and bioinformatics identifies MicroRNA-21 and its target genes as biomarkers for colorectal adenocarcinoma.
    Saheb Sharif-Askari N; Saheb Sharif-Askari F; Guraya SY; Bendardaf R; Hamoudi R
    Int J Surg; 2020 Jan; 73():113-122. PubMed ID: 31756546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.